Overview of COI Management at the University of Pittsburgh

1
Overview of COI Management at the University of
Pittsburgh

• Review at school/ departmental level
• Review by institutional committees
• Review of referrals from other units
• COI management strategies

2
Review at school/departmental level

• COI disclosure by University employee
• Review by department chair/director
• Review by dean
• Review by provost or senior vice chancellor for
  health sciences

3
Review by institutional committees

• COI Committee
• Human subject research
• Animal subject research
• Research on the clinically brain-dead
• Recombinant DNA research
• Embryonic stem cell research
• Entrepreneurial Oversight Committee
• Start-up companies with options or licenses to
  University technology

4
Review of referrals from other units

• Office of Research
• COIs involving federal and industry-sponsored
  research
• Purchasing Department
• Procurement COIs
• Office of Technology Management
• COIs arising from technology transfer

5
Possible COI management strategies

• Prospective supervisory approval for engaging in
  outside professional activities
• Dilution of investigators role in study, i.e.,
  cannot be PI, but may be co-investigator
• Cannot solely be involved in the interpretation
  of study results, but may be involved as part of
  a committee
• Establishment of a data stewardship committee

6
Possible COI management strategies

• Disclosure of the potential COI in the informed
  consent form
• Disclosure of COI in publications, presentations,
  press releases, abstracts, and in proposals and
  applications for research funding
• Divestment or reduction of financial interest